Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC76

Pertuzumab

  • Status:
    Veitt
  • Application date:
    2.9.2013
  • Application published:
    15.9.2013
  • Grant published:
    15.8.2015
  • Max expiry date:
    5.3.2028
  • Next due date:
    31.10.2026
  • Medicine name:
    Perjeta
  • Medicine for children:
    No

Timeline

Today
2.9.2013Application
15.9.2013Publication
15.8.2015Registration
18.10.2026Expires

Marketing license

  • IS authorization number:
    EU/1/13/813/001
  • Date:
    20.3.2013
  • Foreign authorization number:
    EU/1/13/813/001
  • Date:
    4.3.2013

Owner

  • Name:
    Genentech, Inc.
  • Address:
    1 DNA Way, South San Francisco US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 12.8.2025

Expires: 18.10.2026

Payer: Árnason Faktor ehf.

Upload documents